AYTU

NASDAQ HEALTHCARE

Aytu BioScience Inc

$2.31

$0.03 (+1.32%)

Live quote

52w: $1.65 – $3.07

Loading chart…

P/E Ratio—

P/B Ratio0.70

EV/EBITDA—

Debt/Equity—

ROE-40.40%

ROIC—

Revenue Growth-13.27%

Gross Margin63.95%

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and marketing novel products in the field of hypogonadism (low testosterone levels), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company is headquartered in Englewood, Colorado.

Own AYTU? Track it here.

Create a free account to add AYTU to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account